CareDx (CDNA) Tops Q2 EPS by 36c, beats revenue

CareDx (NASDAQ: CDNA) reported Q2 EPS of ($0.18), $0.36 better than the analyst estimate of ($0.54). Revenue for the quarter came in at $70.3 million versus the consensus estimate of $61.77 million.

For earnings history and earnings-related data on CareDx (CDNA) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• United Community Banks sells equipment finance unit for $1.9 billion
• Guggenheim Reiterates Buy Rating on StubHub Holdings (STUB)